CDKN1A and prostate carcinoma: In particular, EGCG could epigenetically reactivate p21/waf1, Bax and PUMA in prostate cancer cell lines, promoting the block of cell cycle and cell death induced by degradation at the proteasome of histone deacetylases (HDACs) [177].